21-deoxycortisol has been researched along with Polycystic Ovary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, J; Hague, WM; Honour, JW; Jacobs, HS; Vecsei, P | 1 |
| Grabinski, M; Gruszka, S; Milewicz, A; Szymczak, J; Tupikowska, G | 1 |
2 other study(ies) available for 21-deoxycortisol and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Steroid responses to ACTH in women with polycystic ovaries.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Cortodoxone; Cosyntropin; Dehydroepiandrosterone; Female; Heterozygote; Humans; Hydroxyprogesterones; Middle Aged; Polycystic Ovary Syndrome; Steroids | 1989 |
The effect of treatment with defined spleen dialysate on plasma levels of 21-deoxycortisol and 17-hydroxyprogesterone in women with polycystic ovary disease.
Topics: 17-alpha-Hydroxyprogesterone; 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Adult; Chorionic Gonadotropin; Cortodoxone; Dialysis; Female; Humans; Hydroxyprogesterones; Polycystic Ovary Syndrome; Spleen | 1985 |